DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Treatment of Hyperhidrosis With Oxybutynin

Information source: University Hospital, Brest
ClinicalTrials.gov processed this data on August 23, 2015
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Hyperhidrosis

Intervention: Oxybutynin (Drug); Placebo (Drug)

Phase: Phase 3

Status: Completed

Sponsored by: University Hospital, Brest

Official(s) and/or principal investigator(s):
Martine SCHOLLHAMMER, MD, Principal Investigator, Affiliation: ADBO


Evaluation of the effectiveness of oxybutynin in hyperhidrosis

Clinical Details

Official title: Treatment of Hyperhidrosis With Oxybutynin: a Randomized Controlled Double Blind Against Placebo

Study design: Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment

Primary outcome: Evaluation of the effectiveness of oxybutynin in hyperhidrosis

Secondary outcome: Safety evaluation of treatment in this indication


Minimum age: 18 Years. Maximum age: N/A. Gender(s): Both.


Inclusion Criteria:

- Age greater than 18 years

- Patient affiliated to social security or beneficiary of such a regime

- Patient able to consent

- Patient with hyperhidrosis, generalized or localized (palmar, plantar, axillary) and

whose score HDSS (Hyperidrosis Disease Severity Scale) is greater than two. Exclusion Criteria:

- Age less than 18 years

- Patient who can't be followed

- Patient participating in another clinical trial

- Pregnant

- Woman breastfeeding

- Hypersensitivity to oxybutynin or any of the excipients

- Risk of urinary retention related disorders uretroprostatiques

- Intestinal obstruction

- Toxic megacolon

- Intestinal atony

- Severe Ulcerative Colitis

- Myasthenia

- Closure glaucoma the anterior chamber angle or slightly deep

Locations and Contacts

Hospital, Brest, Brest 29609, France

CHG Landerneau, Landerneau 29800, France

CHG de Morlaix, Morlaix 29600, France

Dermatologist'S Office, Quimper 29000, France

Additional Information

Starting date: June 2013
Last updated: July 7, 2014

Page last updated: August 23, 2015

-- advertisement -- The American Red Cross
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017